Literature DB >> 23601201

Evaluation of total oxidant and antioxidant status in localized and generalized vitiligo.

G Akoglu1, S Emre, A Metin, A Akbas, A Yorulmaz, S Isikoglu, S Sener, F Kilinc.   

Abstract

BACKGROUND: Vitiligo is an acquired depigmentation disorder, and oxidative stress is suggested to have a major role in its aetiopathogenesis. AIM: To assess whether oxidative stress has a greater role in generalized than in localized vitiligo.
METHODS: We assessed 31 patients with active vitiligo (17 localized, 14 generalized) and 38 healthy controls. Serum total oxidant status (TOS), total antioxidant status (TAS) and oxidative stress index (OSI) were determined.
RESULTS: Patients with vitiligo had significantly lower TAS and higher TOS and OSI values than controls. Both localized and generalized vitiligo were associated with lower TAS and higher TOS and OSI values, compared with controls, and all three did not differ with vitiligo type.
CONCLUSIONS: A systemic oxidative stress exists in patients with vitiligo. These results indicate that the global antioxidant capacity of patients might have been exhausted through a defence mechanism against oxidative processes. The imbalance in TOS/TAS status may have an important role in the aetiopathogenesis of vitiligo, regardless of the clinical variant of the disease.
© 2013 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23601201     DOI: 10.1111/ced.12054

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  10 in total

1.  Changes of total antioxidant capacity and total oxidant status of aqueous humor in diabetes patients and correlations with diabetic retinopathy.

Authors:  Emrullah Beyazyıldız; Ali Bülent Cankaya; Esra Ergan; Mustafa Alparslan Anayol; Yasemin Ozdamar; Sevilay Sezer; Mehmet Hakan Tırhış; Pelin Yılmazbaş; Faruk Oztürk
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

Review 2.  Update on the pathogenesis of vitiligo.

Authors:  Helena Zenedin Marchioro; Caio César Silva de Castro; Vinicius Medeiros Fava; Paula Hitomi Sakiyama; Gerson Dellatorre; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2022-05-25       Impact factor: 2.113

3.  Decreased glucose-6-phosphate dehydrogenase levels in vitiligo patients: Further evidence of oxidative stress.

Authors:  Amir Farahi-Jahromy; Mohammad Kazem Fallahzadeh; Soheil Ashkani-Esfahani; Nasrin Hamidizadeh; Mahsa Ghavipisheh; Mohammad Reza Namazi
Journal:  Adv Biomed Res       Date:  2014-01-09

4.  Evaluation of advanced oxidation protein products, prooxidant-antioxidant balance, and total antioxidant capacity in untreated vitiligo patients.

Authors:  Gülcan Güntaş; Burhan Engin; Özlem Balcı Ekmekçi; Zekayi Kutlubay; Hakan Ekmekci; Abdullah Songür; Tuğba Kevser Üstünbaş Uzunçakmak; Hayriye Ertem Vehid; Server Serdaroğlu; Yalçın Tüzün; Hafize Uzun
Journal:  Ann Dermatol       Date:  2015-03-24       Impact factor: 1.444

5.  Serum Homocysteine and Total Antioxidant Status in Vitiligo: A Case Control Study in Indian Population.

Authors:  Shikha Gupta; Paschal D'souza; Tapan Kumar Dhali; Sarika Arora
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

Review 6.  Antioxidants in dermatology.

Authors:  Flavia Alvim Sant'anna Addor
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

7.  6-Shogaol Protects Human Melanocytes against Oxidative Stress through Activation of the Nrf2-Antioxidant Response Element Signaling Pathway.

Authors:  Lingli Yang; Fei Yang; Lanting Teng; Ichiro Katayama
Journal:  Int J Mol Sci       Date:  2020-05-16       Impact factor: 5.923

Review 8.  Oxidative stress and alopecia areata.

Authors:  B E Prie; V M Voiculescu; O B Ionescu-Bozdog; B Petrutescu; L Iosif; L E Gaman; V G Clatici; I Stoian; C Giurcaneanu
Journal:  J Med Life       Date:  2015

9.  Evaluation of the Efficacy of Topical Ethyl Vanillate in Enhancing the Effect of Narrow Band Ultraviolet B against Vitiligo: A Double Blind Randomized, Placebo-Controlled Clinical Trial.

Authors:  Mohammad Reza Namazi; Amir Kalafi Shotorbani
Journal:  Iran J Med Sci       Date:  2015-11

10.  Ischemia-modified albumin as a possible marker of oxidative stress in patients with telogen effluvium.

Authors:  Unsal Savci; Engin Senel; Aynure Oztekin; Mustafa Sungur; Ozcan Erel; Salim Neselioglu
Journal:  An Bras Dermatol       Date:  2020-05-06       Impact factor: 1.896

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.